TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Non-Invasive Drug Delivery Market, Global Outlook and Forecast 2023-2032

Non-Invasive Drug Delivery Market, Global Outlook and Forecast 2023-2032

  • Category:Life Sciences
  • Published on : 05 October 2023
  • Pages :107
  • Formats:
  • Report Code:SMR-7823665
OfferClick for best price

Best Price: $2600

NonInvasive Drug Delivery Market Size, Share 2023


This report aims to provide a comprehensive presentation of the global market for Non-Invasive Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Drug Delivery. This report contains market size and forecasts of Non-Invasive Drug Delivery in global, including the following market information:

Global Non-Invasive Drug Delivery Market Revenue, 2018-2023, 2024-2032, ($ millions)

Global top five companies in 2022 (%)

The global Non-Invasive Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.

Artificial Pancreas Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Non-Invasive Drug Delivery include Adherium Limited, Capsule Technologies, Inc., Crossject S.A., Diabeloop SA, HNS International, Inc., Inovio Pharmaceuticals, Inc., Medtronic Plc., Novartis AG and PenJet Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Non-Invasive Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-Invasive Drug Delivery Market, by Type, 2018-2023, 2024-2032 ($ millions)

Global Non-Invasive Drug Delivery Market Segment Percentages, by Type, 2022 (%)

Artificial Pancreas

Needle Free Injector

Digital Respiratory Devices

Other

Global Non-Invasive Drug Delivery Market, by Application, 2018-2023, 2024-2032 ($ millions)

Global Non-Invasive Drug Delivery Market Segment Percentages, by Application, 2022 (%)

Hospital

Clinic

Other

Global Non-Invasive Drug Delivery Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)

Global Non-Invasive Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-Invasive Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)

Key companies Non-Invasive Drug Delivery revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Adherium Limited

Capsule Technologies, Inc.

Crossject S.A.

Diabeloop SA

HNS International, Inc.

Inovio Pharmaceuticals, Inc.

Medtronic Plc.

Novartis AG

PenJet Corporation

PharmaJet

Portal Instruments

ResMed

Sensiron AG

Tandem Diabetes Care, Inc.

Teva Pharmaceuticals Industries Ltd.

Outline of Major Chapters:

Chapter 1: Introduces the definition of Non-Invasive Drug Delivery, market overview.

Chapter 2: Global Non-Invasive Drug Delivery market size in revenue.

Chapter 3: Detailed analysis of Non-Invasive Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-Invasive Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

Report Attributes Report Details
Report Title Non-Invasive Drug Delivery Market, Global Outlook and Forecast 2023-2032
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 107 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Non-Invasive Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Invasive Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Invasive Drug Delivery Overall Market Size
2.1 Global Non-Invasive Drug Delivery Market Size: 2022 VS 2032
2.2 Global Non-Invasive Drug Delivery Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Invasive Drug Delivery Players in Global Market
3.2 Top Global Non-Invasive Drug Delivery Companies Ranked by Revenue
3.3 Global Non-Invasive Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Non-Invasive Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-Invasive Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Invasive Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Non-Invasive Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Invasive Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-Invasive Drug Delivery Market Size Markets, 2022 & 2032
4.1.2 Artificial Pancreas
4.1.3 Needle Free Injector
4.1.4 Digital Respiratory Devices
4.1.5 Other
4.2 By Type - Global Non-Invasive Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Non-Invasive Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Non-Invasive Drug Delivery Revenue, 2024-2032
4.2.3 By Type - Global Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-Invasive Drug Delivery Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Non-Invasive Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Non-Invasive Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Non-Invasive Drug Delivery Revenue, 2024-2032
5.2.3 By Application - Global Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Non-Invasive Drug Delivery Market Size, 2022 & 2032
6.2 By Region - Global Non-Invasive Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Non-Invasive Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Non-Invasive Drug Delivery Revenue, 2024-2032
6.2.3 By Region - Global Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Non-Invasive Drug Delivery Revenue, 2018-2032
6.3.2 US Non-Invasive Drug Delivery Market Size, 2018-2032
6.3.3 Canada Non-Invasive Drug Delivery Market Size, 2018-2032
6.3.4 Mexico Non-Invasive Drug Delivery Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Non-Invasive Drug Delivery Revenue, 2018-2032
6.4.2 Germany Non-Invasive Drug Delivery Market Size, 2018-2032
6.4.3 France Non-Invasive Drug Delivery Market Size, 2018-2032
6.4.4 U.K. Non-Invasive Drug Delivery Market Size, 2018-2032
6.4.5 Italy Non-Invasive Drug Delivery Market Size, 2018-2032
6.4.6 Russia Non-Invasive Drug Delivery Market Size, 2018-2032
6.4.7 Nordic Countries Non-Invasive Drug Delivery Market Size, 2018-2032
6.4.8 Benelux Non-Invasive Drug Delivery Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Non-Invasive Drug Delivery Revenue, 2018-2032
6.5.2 China Non-Invasive Drug Delivery Market Size, 2018-2032
6.5.3 Japan Non-Invasive Drug Delivery Market Size, 2018-2032
6.5.4 South Korea Non-Invasive Drug Delivery Market Size, 2018-2032
6.5.5 Southeast Asia Non-Invasive Drug Delivery Market Size, 2018-2032
6.5.6 India Non-Invasive Drug Delivery Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Non-Invasive Drug Delivery Revenue, 2018-2032
6.6.2 Brazil Non-Invasive Drug Delivery Market Size, 2018-2032
6.6.3 Argentina Non-Invasive Drug Delivery Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Invasive Drug Delivery Revenue, 2018-2032
6.7.2 Turkey Non-Invasive Drug Delivery Market Size, 2018-2032
6.7.3 Israel Non-Invasive Drug Delivery Market Size, 2018-2032
6.7.4 Saudi Arabia Non-Invasive Drug Delivery Market Size, 2018-2032
6.7.5 UAE Non-Invasive Drug Delivery Market Size, 2018-2032
7 Non-Invasive Drug Delivery Companies Profiles
7.1 Adherium Limited
7.1.1 Adherium Limited Company Summary
7.1.2 Adherium Limited Business Overview
7.1.3 Adherium Limited Non-Invasive Drug Delivery Major Product Offerings
7.1.4 Adherium Limited Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 Adherium Limited Key News & Latest Developments
7.2 Capsule Technologies, Inc.
7.2.1 Capsule Technologies, Inc. Company Summary
7.2.2 Capsule Technologies, Inc. Business Overview
7.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Major Product Offerings
7.2.4 Capsule Technologies, Inc. Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Capsule Technologies, Inc. Key News & Latest Developments
7.3 Crossject S.A.
7.3.1 Crossject S.A. Company Summary
7.3.2 Crossject S.A. Business Overview
7.3.3 Crossject S.A. Non-Invasive Drug Delivery Major Product Offerings
7.3.4 Crossject S.A. Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Crossject S.A. Key News & Latest Developments
7.4 Diabeloop SA
7.4.1 Diabeloop SA Company Summary
7.4.2 Diabeloop SA Business Overview
7.4.3 Diabeloop SA Non-Invasive Drug Delivery Major Product Offerings
7.4.4 Diabeloop SA Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Diabeloop SA Key News & Latest Developments
7.5 HNS International, Inc.
7.5.1 HNS International, Inc. Company Summary
7.5.2 HNS International, Inc. Business Overview
7.5.3 HNS International, Inc. Non-Invasive Drug Delivery Major Product Offerings
7.5.4 HNS International, Inc. Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 HNS International, Inc. Key News & Latest Developments
7.6 Inovio Pharmaceuticals, Inc.
7.6.1 Inovio Pharmaceuticals, Inc. Company Summary
7.6.2 Inovio Pharmaceuticals, Inc. Business Overview
7.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Major Product Offerings
7.6.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 Inovio Pharmaceuticals, Inc. Key News & Latest Developments
7.7 Medtronic Plc.
7.7.1 Medtronic Plc. Company Summary
7.7.2 Medtronic Plc. Business Overview
7.7.3 Medtronic Plc. Non-Invasive Drug Delivery Major Product Offerings
7.7.4 Medtronic Plc. Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Medtronic Plc. Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Non-Invasive Drug Delivery Major Product Offerings
7.8.4 Novartis AG Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 PenJet Corporation
7.9.1 PenJet Corporation Company Summary
7.9.2 PenJet Corporation Business Overview
7.9.3 PenJet Corporation Non-Invasive Drug Delivery Major Product Offerings
7.9.4 PenJet Corporation Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 PenJet Corporation Key News & Latest Developments
7.10 PharmaJet
7.10.1 PharmaJet Company Summary
7.10.2 PharmaJet Business Overview
7.10.3 PharmaJet Non-Invasive Drug Delivery Major Product Offerings
7.10.4 PharmaJet Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 PharmaJet Key News & Latest Developments
7.11 Portal Instruments
7.11.1 Portal Instruments Company Summary
7.11.2 Portal Instruments Business Overview
7.11.3 Portal Instruments Non-Invasive Drug Delivery Major Product Offerings
7.11.4 Portal Instruments Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.11.5 Portal Instruments Key News & Latest Developments
7.12 ResMed
7.12.1 ResMed Company Summary
7.12.2 ResMed Business Overview
7.12.3 ResMed Non-Invasive Drug Delivery Major Product Offerings
7.12.4 ResMed Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.12.5 ResMed Key News & Latest Developments
7.13 Sensiron AG
7.13.1 Sensiron AG Company Summary
7.13.2 Sensiron AG Business Overview
7.13.3 Sensiron AG Non-Invasive Drug Delivery Major Product Offerings
7.13.4 Sensiron AG Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.13.5 Sensiron AG Key News & Latest Developments
7.14 Tandem Diabetes Care, Inc.
7.14.1 Tandem Diabetes Care, Inc. Company Summary
7.14.2 Tandem Diabetes Care, Inc. Business Overview
7.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Major Product Offerings
7.14.4 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.14.5 Tandem Diabetes Care, Inc. Key News & Latest Developments
7.15 Teva Pharmaceuticals Industries Ltd.
7.15.1 Teva Pharmaceuticals Industries Ltd. Company Summary
7.15.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Major Product Offerings
7.15.4 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Revenue in Global Market (2018-2023)
7.15.5 Teva Pharmaceuticals Industries Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Non-Invasive Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Non-Invasive Drug Delivery Market Drivers in Global Market
Table 3. Non-Invasive Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Non-Invasive Drug Delivery in Global Market
Table 5. Top Non-Invasive Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Non-Invasive Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Non-Invasive Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Non-Invasive Drug Delivery Product Type
Table 9. List of Global Tier 1 Non-Invasive Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Invasive Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non-Invasive Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Non-Invasive Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Non-Invasive Drug Delivery Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Non-Invasive Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Non-Invasive Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Non-Invasive Drug Delivery Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Non-Invasive Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Non-Invasive Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Non-Invasive Drug Delivery Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Non-Invasive Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Non-Invasive Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Non-Invasive Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Non-Invasive Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Non-Invasive Drug Delivery Revenue, (US$, Mn), 2024-2032
Table 30. Adherium Limited Company Summary
Table 31. Adherium Limited Non-Invasive Drug Delivery Product Offerings
Table 32. Adherium Limited Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. Adherium Limited Key News & Latest Developments
Table 34. Capsule Technologies, Inc. Company Summary
Table 35. Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Offerings
Table 36. Capsule Technologies, Inc. Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Capsule Technologies, Inc. Key News & Latest Developments
Table 38. Crossject S.A. Company Summary
Table 39. Crossject S.A. Non-Invasive Drug Delivery Product Offerings
Table 40. Crossject S.A. Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. Crossject S.A. Key News & Latest Developments
Table 42. Diabeloop SA Company Summary
Table 43. Diabeloop SA Non-Invasive Drug Delivery Product Offerings
Table 44. Diabeloop SA Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. Diabeloop SA Key News & Latest Developments
Table 46. HNS International, Inc. Company Summary
Table 47. HNS International, Inc. Non-Invasive Drug Delivery Product Offerings
Table 48. HNS International, Inc. Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. HNS International, Inc. Key News & Latest Developments
Table 50. Inovio Pharmaceuticals, Inc. Company Summary
Table 51. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Offerings
Table 52. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. Inovio Pharmaceuticals, Inc. Key News & Latest Developments
Table 54. Medtronic Plc. Company Summary
Table 55. Medtronic Plc. Non-Invasive Drug Delivery Product Offerings
Table 56. Medtronic Plc. Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Medtronic Plc. Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Non-Invasive Drug Delivery Product Offerings
Table 60. Novartis AG Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. PenJet Corporation Company Summary
Table 63. PenJet Corporation Non-Invasive Drug Delivery Product Offerings
Table 64. PenJet Corporation Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 65. PenJet Corporation Key News & Latest Developments
Table 66. PharmaJet Company Summary
Table 67. PharmaJet Non-Invasive Drug Delivery Product Offerings
Table 68. PharmaJet Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 69. PharmaJet Key News & Latest Developments
Table 70. Portal Instruments Company Summary
Table 71. Portal Instruments Non-Invasive Drug Delivery Product Offerings
Table 72. Portal Instruments Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 73. Portal Instruments Key News & Latest Developments
Table 74. ResMed Company Summary
Table 75. ResMed Non-Invasive Drug Delivery Product Offerings
Table 76. ResMed Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 77. ResMed Key News & Latest Developments
Table 78. Sensiron AG Company Summary
Table 79. Sensiron AG Non-Invasive Drug Delivery Product Offerings
Table 80. Sensiron AG Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 81. Sensiron AG Key News & Latest Developments
Table 82. Tandem Diabetes Care, Inc. Company Summary
Table 83. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Offerings
Table 84. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 85. Tandem Diabetes Care, Inc. Key News & Latest Developments
Table 86. Teva Pharmaceuticals Industries Ltd. Company Summary
Table 87. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Offerings
Table 88. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 89. Teva Pharmaceuticals Industries Ltd. Key News & Latest Developments
List of Figures
Figure 1. Non-Invasive Drug Delivery Segment by Type in 2022
Figure 2. Non-Invasive Drug Delivery Segment by Application in 2022
Figure 3. Global Non-Invasive Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-Invasive Drug Delivery Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Non-Invasive Drug Delivery Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Invasive Drug Delivery Revenue in 2022
Figure 8. By Type - Global Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 9. By Application - Global Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 10. By Type - Global Non-Invasive Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 12. By Application - Global Non-Invasive Drug Delivery Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 14. By Region - Global Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 15. By Country - North America Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 16. US Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 20. Germany Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 21. France Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 28. China Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 32. India Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 34. Brazil Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Non-Invasive Drug Delivery Revenue Market Share, 2018-2032
Figure 37. Turkey Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Non-Invasive Drug Delivery Revenue, (US$, Mn), 2018-2032
Figure 41. Adherium Limited Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Capsule Technologies, Inc. Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Crossject S.A. Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Diabeloop SA Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. HNS International, Inc. Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Medtronic Plc. Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis AG Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. PenJet Corporation Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. PharmaJet Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Portal Instruments Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. ResMed Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sensiron AG Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount